Lille Catholic University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Lille France (1875)

Organization Overview

First Clinical Trial
2008
NCT00852228
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

CRESGE | Lille Catholic University | Universite Catholique de Lille

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Chondrocalcinosis (Phase 4)

Colorectal Neoplasms (Phase 2)

Joint Diseases (Phase 2)

Liver Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms, Second Primary (Phase 2)

Osteoarthritis, Knee (Phase 2)

Pain, Intractable (Phase 4)

Pressure Ulcer (Phase 4)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 13